MetaCap

Nautilus Biotechnology Statistics

NASDAQ: NAUTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

2.12-0.05 (-2.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Nautilus Biotechnology by the numbers

Nautilus Biotechnology has a market capitalization of $270.0 million based on 127.37M shares outstanding. With trailing EPS of $-0.46, Nautilus Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.3% above its 50-day average and 0.7% below its 200-day average.

Average daily trading volume is 6.25M shares, or about $13.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NAUT valuation vs. peer median

NAUT compared with the median of 8 peer companies
MetricNAUTPeer medianDifference
Market cap$270.03M$57.76M+368%
Avg. volume6.25M649.32K+863%

Peer median across 8 companies: LAB, QTRX, SEER, HBIO, RPID, PACB, PRPO, EYPT.

Valuation

Price and trading

Previous close
2.17
Open
2.12
Day range
1.91 – 2.17
52-week range
0.841 – 4.31
52-week change
-5.36%
Beta
—
Volume
6.24M

Dividends and events

Annual dividend
None
Next earnings date
Oct 27, 2026

Additional statistics

Market Cap
270.03M
Forward Pe
-2.86
Eps
-0.46
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.31
Week52 Low
0.84
Avg Volume
6.25M
Shares Outstanding
127.37M
Ma50
2.00
Ma200
2.13
Earnings Date
Oct 27, 2026
Pct From52w High
-50.81%
Pct From52w Low
152.08%

Related